Skip to main content

Oral Anticoagulation in Patients with End Stage Renal Disease and Atrial Fibrillation: The Need to Evaluate Net Clinical Effect.

Publication ,  Journal Article
Patel, MR; Piccini, JP
Published in: Circulation
January 19, 2016

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

January 19, 2016

Volume

133

Issue

3

Start / End Page

242 / 244

Location

United States

Related Subject Headings

  • Stroke
  • Renal Dialysis
  • Male
  • Humans
  • Hospital Mortality
  • Female
  • Cardiovascular System & Hematology
  • Atrial Fibrillation
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Patel, M. R., & Piccini, J. P. (2016). Oral Anticoagulation in Patients with End Stage Renal Disease and Atrial Fibrillation: The Need to Evaluate Net Clinical Effect. Circulation, 133(3), 242–244. https://doi.org/10.1161/CIRCULATIONAHA.115.020378
Patel, Manesh R., and Jonathan P. Piccini. “Oral Anticoagulation in Patients with End Stage Renal Disease and Atrial Fibrillation: The Need to Evaluate Net Clinical Effect.Circulation 133, no. 3 (January 19, 2016): 242–44. https://doi.org/10.1161/CIRCULATIONAHA.115.020378.
Patel, Manesh R., and Jonathan P. Piccini. “Oral Anticoagulation in Patients with End Stage Renal Disease and Atrial Fibrillation: The Need to Evaluate Net Clinical Effect.Circulation, vol. 133, no. 3, Jan. 2016, pp. 242–44. Pubmed, doi:10.1161/CIRCULATIONAHA.115.020378.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

January 19, 2016

Volume

133

Issue

3

Start / End Page

242 / 244

Location

United States

Related Subject Headings

  • Stroke
  • Renal Dialysis
  • Male
  • Humans
  • Hospital Mortality
  • Female
  • Cardiovascular System & Hematology
  • Atrial Fibrillation
  • 4207 Sports science and exercise
  • 3202 Clinical sciences